EI
ABMD

EAM Investors’s Abiomed Inc ABMD Stock Holding History

EAM Investors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-24,768
Closed -$3.19M – 383
2016
Q3 		$3.19M Sell
24,768
-642
-3% -$76.9K 0.43% 71
2016
Q2 		$2.78M Buy
+25,410
New +$2.53M 0.42% 86
2016
Q1 		– Sell
-37,744
Closed -$3.41M – 361
2015
Q4 		$3.41M Buy
37,744
+8,115
+27% +$689K 0.45% 80
2015
Q3 		$2.75M Sell
29,629
-6,885
-19% -$607K 0.44% 75
2015
Q2 		$2.4M Sell
36,514
-19,063
-34% -$1.27M 0.28% 162
2015
Q1 		$3.98M Sell
55,577
-17,943
-24% -$974K 0.46% 50
2014
Q4 		$2.8M Buy
+73,520
New +$2.32M 0.39% 83

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM Investors's ABMD Position: Q4 2016 in Review

EAM Investors sold out of Abiomed Inc (ABMD) in Q4 2016, closing a stake of 24,768 shares — an estimated $3.19M sold.

EAM Investors first reported a position in ABMD in Q4 2014 and held it in 7 quarters. The position peaked at $3.98M in Q1 2015. 297 funds tracked by Wall St. Rank hold ABMD as of Q4 2016.

  • EAM Investors reported no remaining Abiomed Inc position as of Q4 2016 after selling out during the quarter.
  • EAM Investors sold 24,768 Abiomed Inc shares in Q4 2016, an estimated $3.19M.
  • EAM Investors first reported a position in Abiomed Inc in Q4 2014 and held it in 7 quarters.
  • EAM Investors's Abiomed Inc position peaked at $3.98M in Q1 2015.
  • 297 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2016.

Based on EAM Investors's 13F filing for Q4 2016, filed 14 Feb 2017.